On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayJun 06, 2017 9:29 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Teams with First Bitcoin Capital (BITCF) to Develop Bitcoin Payments Solution

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced an initiative to develop a bitcoin payments solution in partnership with First Bitcoin Capital Corp. (OTC: BITCF), an industry-leading bitcoin and blockchain technology provider. Per the news release, the two companies have signed a joint venture agreement to develop and distribute a viable payments solution targeted at “high-risk payment verticals including the cannabis industry” in order to “fill the payments gap that currently exists.” Through this new partnership, SinglePoint and First Bitcoin Capital intend to focus on their respective core strengths in order to build and supply the best bitcoin…

Continue Reading

TuesdayJun 06, 2017 9:01 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Engagement of Venture Building Firm Launch Haus, LLC

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its engagement of Launch Haus, LLC, a venture building firm and digital holding company specializing in direct response marketing. Moving forward, Launch Haus is expected to play an “integral part” in directing CIIX’s corporate organization, as well as its planned launch of direct-to-consumer ecommerce and network marketing business divisions. “Launch Haus is the perfect firm to oversee CIIX's direct response marketing campaign which will include significant direct-to-consumer ecommerce channels such as Amazon and development of the Company's international network marketing platform as we begin to drive revenues in the coming…

Continue Reading

FridayJun 02, 2017 1:31 pm

QualityStocksNewsBreak – Asure Software, Inc. (NASDAQ: ASUR) Engages ROTH Capital as Sole Book-Running Manager in $29.5M Public Offering

Asure Software (NASDAQ: ASUR) has successfully completed an underwritten public offering of 2,185,000 shares of its common stock at the public offering price of $13.50 per share, which includes the sale of 285,000 additional shares pursuant to the full exercise of the over-allotment option granted to the underwriters. ROTH Capital Partners acted as the sole book-running manager for the offering. Gross proceeds for Asure totaled $29.5 million, which the company plans to use toward general corporate purposes and to potentially acquire or invest in complementary businesses, assets or technologies. The company has not entered into any definitive agreement with respect…

Continue Reading

FridayJun 02, 2017 10:21 am

QualityStocksNewsBreak – Player’s Network, Inc. (PNTV) Completes First Phase of Construction for Green Leaf Farms Cultivation and Production Facility

Player’s Network, Inc. (OTCQB: PNTV) this morning announced the completion of the the first phase of its 27,000-sq.-ft. facility being built in North Las Vegas for its subsidiary Green Leak Farms Holdings. mCig, Inc. (OTCQB: MCIG), the company contracted to develop and build out the facility, worked with the City of North Las Vegas and the State of Nevada to ensure Green Leaf was 100% compliant. The first phase included two vegetation and flower rooms, an extraction lab and all the needed infrastructure to support the facility. According to the press release, phase 2 and phase 3 are nearing completion…

Continue Reading

FridayJun 02, 2017 10:18 am

QualityStocksNewsBreaks – Exactus, Inc. (EXDI) Receives $1.60 PT from SeeThruEquity

SeeThruEquity has initiated coverage and issued a price target of $1.60 on shares of Exactus, Inc. (OTCQB: EXDI). The analyst noted that the company has an intriguing lineup of point-of-care (POC) diagnostic solutions designed to improve the markets for fibrinolytic and cancer screening. Exactus’ initial products, the FibriLyzer™ and MatriLyzer™, are POC diagnostics that can produce results from only a drop of blood, saving time and cost compared to the currently available methods. The market for POC diagnostics is set to reach to $26.3 billion by 2021, and the analyst believes the company’s diagnostics have the potential to be disruptive…

Continue Reading

WednesdayMay 31, 2017 3:26 pm

QualityStocksNewsBreak – Aegis Capital Reiterates “Buy” Rating on CytoSorbents Corp. (NASDAQ: CTSO)

Following CytoSorbents Corp.’s (NASDAQ: CTSO) appointment of a new chief medical officer (CMO), Aegis Capital reiterated its ‘Buy’ rating and price target of $9 on shares of the company’s stock. The company recently named Dr. Eric G. Mortensen, M.D., Ph.D., as its new CMO, starting full-time tomorrow. Dr. Mortensen holds an M.D. from Harvard University and Massachusetts Institute of Technology Division of Health Sciences and Technology, and a Ph.D. in biophysics from the Harvard Graduate School of Arts and Sciences. Former CMO Dr. Robert H. Bartlett, M.D. will retire after nine years with the company, but will remain as a…

Continue Reading

WednesdayMay 31, 2017 3:24 pm

QualityStocksNewsBreak – MEI Pharma, Inc. (NASDAQ: MEIP) Exceeds Pre-Specified Response Rate Study of ME-401 in CLL and Follicular Lymphoma

Shares of MEI Pharma (NASDAQ: MEIP) are higher in mid-day trade on news that an independent Safety Review Committee has completed its pre-specified review of the first cohort of six evaluable patients in a phase Ib study of the company’s potent and selective oral PI3K delta inhibitor, ME-401, in relapsed/refractory chronic lymphocytic leukemia (CLL) and follicular lymphoma. “PI3K delta inhibitors have demonstrated clear activity in the treatment of CLL and follicular lymphoma, but at the expense of well-defined and substantial toxicities. We believe this provides an opportunity for a highly differentiated drug that is both effective and safe. Now we…

Continue Reading

WednesdayMay 31, 2017 3:20 pm

QualityStocksNewsBreak – EMA Committee for Orphan Medicinal Products Recommends Designation for Catalyst Biosciences, Inc.’s (NASDAQ: CBIO) Factor IX

Shares of Catalyst Biosciences (NASDAQ: CBIO) are 15% higher this morning on news that a positive opinion recommending orphan medicinal product designation has been issued by the European Medicines Agency Committee (EMA) for Orphan Medicinal Products (COMP) regarding Catalyst’s CB 2679d for the treatment of hemophilia B. The clinical-stage biopharmaceutical company’s highly potent next-generation coagulation Factor IX variant demonstrated potential to normalize human Factor IX levels with a daily subcutaneous injection in preclinical studies. Currently approved therapies rely on numerous intravenous infusions. “Obtaining orphan drug designation is an important part of our regulatory approval strategy for CB 2679d, and the…

Continue Reading

TuesdayMay 30, 2017 1:09 pm

QualityStocksNewsBreaks – Player’s Network, Inc. (PNTV): New Medical Marijuana Licenses Enable the Start of Cultivation and Production Operations

Player’s Network (OTCQB: PNTV) today achieved a corporate milestone as it received its medical marijuana licenses that permit the company to commence operations in its 27,000-square-foot facility in North Las Vegas. The company’s plans to become fully operational include activating the core processes necessary to commence cultivation and production operations. Green Leaf Holdings, the company’s subsidiary, is set to begin planting this week under its Cultivation License. “This has been a long journey through the mountains of paperwork and regulatory requirements to become fully compliant. Now we can finally put our plan into place and focus on developing amazing brands…

Continue Reading

TuesdayMay 30, 2017 1:00 pm

QualityStocksNewsBreaks – Reopened Patent Case Sends ParkerVision, Inc. (NASDAQ: PRKR) Shares Higher

ParkerVision (NASDAQ: PRKR) shares are up 9% in mid-day trade after the radio-frequency technologies company said its request to lift the stay and reopen its patent infringement case against Apple (NASDAQ: AAPL), LG and Qualcomm (NASDAQ: QCOM) was granted by the Middle District of Florida. Additionally, the court ordered the parties to conduct a case management conference within 30 days and subsequently file a case management report within the 14 days following the conference. The company filed its request to reopen the case on May 4 after the International Trade Commission’s ruling to approve the company’s motion to terminate its…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered